{"title":"Donald W Light","description":null,"products":[{"product_id":"risks-of-prescription-drugs-book-donald-w-light-9780231146937","title":"The Risks of Prescription Drugs","description":"Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions.  The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected.  Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective.  Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks.  Additional Columbia \/ SSRC books on the privatization of risk and its implications for Americans:  Bailouts: Public Money, Private ProfitEdited by Robert E. Wright  Disaster and the Politics of InterventionEdited by Andrew Lakoff  Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker  Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman  Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein","brand":"WoB","offers":[{"title":"GB \/ VERY_GOOD \/ INTERNAL","offer_id":49535675269393,"sku":"GOR010865693","price":0.0,"currency_code":"GBP","in_stock":false},{"title":"US \/ GOOD \/ SBYB","offer_id":50347071897873,"sku":"CIN0231146930G","price":0.0,"currency_code":"GBP","in_stock":false},{"title":"US \/ VERY_GOOD \/ SBYB","offer_id":52496439410961,"sku":"CIN0231146930VG","price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/0231146930.jpg?v=1751195282"},{"product_id":"sociology-book-donald-w-light-9780070380691","title":"Sociology","description":"This survey focuses on five key concepts to explain sociological principles: function; structure; action; culture; and power. These concepts enable the text to present structural sociology and culture, with student-orientated examples.","brand":"WoB","offers":[{"title":"US \/ GOOD \/ SBYB","offer_id":49918197367057,"sku":"CIN0070380694G","price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/0070380694.jpg?v=1751195135"},{"product_id":"risks-of-prescription-drugs-book-donald-w-light-9780231146920","title":"The Risks of Prescription Drugs","description":"Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions.  The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected.  Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective.  Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks.  Additional Columbia \/ SSRC books on the privatization of risk and its implications for Americans:  Bailouts: Public Money, Private ProfitEdited by Robert E. Wright  Disaster and the Politics of InterventionEdited by Andrew Lakoff  Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker  Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman  Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein","brand":"WoB","offers":[{"title":"- \/ - \/ -","offer_id":51828470677777,"sku":null,"price":0.0,"currency_code":"GBP","in_stock":true},{"title":"GB \/ NEW \/ GARDNERS","offer_id":51828470939921,"sku":"NGR9780231146920","price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9780231146920.jpg?v=1752754995"},{"product_id":"good-pharma-book-donald-w-light-9781137388339","title":"Good Pharma","description":"Drawing on key concepts in sociology and management, this history describes a remarkable institute that has elevated medical research and worked out solutions to the troubling practices of commercial pharmaceutical research. Good Pharma is the answer to Goldacre's Bad Pharma, ethical research without commercial distortions that mislead doctors and patients. This extended case history of the Mario Negri Institute describes how a brilliant young researcher, Silvio Garattini, and a boldly imaginative philanthropist, Mario Negri, conceived of an independent, ethics-based research institute to develop better medicines for patients. It may sounds obvious; yet patent-based research usually develops minor variations. This book describe the Institute's influence on founding the WHO Essential Medicines List, nurturing the Cochrane Collaboration, and reforming European regulations to reduce commercial influences and increase transparency. The Mario Negri model for pharmacological research and policy offers an alternative to today's costly, wasteful drug development with few benefits for patients. A revolution is needed.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52126291099921,"sku":"NLS9781137388339","price":0.0,"currency_code":"GBP","in_stock":true},{"title":"US \/ NEW \/ INGRAM","offer_id":52746911973649,"sku":"NIN9781137388339","price":0.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781137388339.jpg?v=1757475065"},{"product_id":"good-pharma-book-donald-w-light-9781349678402","title":"Good Pharma","description":"Drawing on key concepts in sociology and management, this history describes a remarkable institute that has elevated medical research and worked out solutions to the troubling practices of commercial pharmaceutical research. Good Pharma is the answer to Goldacre's Bad Pharma, ethical research without commercial distortions that mislead doctors and patients. This extended case history of the Mario Negri Institute describes how a brilliant young researcher, Silvio Garattini, and a boldly imaginative philanthropist, Mario Negri, conceived of an independent, ethics-based research institute to develop better medicines for patients. It may sounds obvious; yet patent-based research usually develops minor variations. This book describe the Institute's influence on founding the WHO Essential Medicines List, nurturing the Cochrane Collaboration, and reforming European regulations to reduce commercial influences and increase transparency. The Mario Negri model for pharmacological research and policy offers an alternative to today's costly, wasteful drug development with few benefits for patients. A revolution is needed.","brand":"WoB","offers":[{"title":"GB \/ NEW \/ INGRAM","offer_id":52339745423633,"sku":"NLS9781349678402","price":0.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0784\/4072\/6801\/files\/9781349678402.jpg?v=1758170099"}],"url":"https:\/\/www.worldofbooks.com\/en-gb\/collections\/author-books-by-donald-w-light.oembed","provider":"World of Books ","version":"1.0","type":"link"}